We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Chutes and Ladders

News List

Ferring’s chief science officer to take over as executive board president in January fiercebiotech
November 02, 2018
Ferring Pharmaceuticals’ chief operating officer and president of its executive board, Michel Pettigrew, announced that he plans to retire Dec. 31.
Curis moves up COO as CEO Fattaey leaves company fiercebiotech
September 27, 2018
James Dentzer has been leading the company’s pre-commercial planning for fimepinostat, which received an FDA fast-track designation in relapsed or refractory diffuse large B-cell lymphoma in May.
Chutes & Ladders—Shire CFO’s abrupt exit worries investors fiercebiotech
August 25, 2017
CFO Jeff Poulton's plan to leave Shire at the end of the year stirred up uneasiness among investors.
Chutes & Ladders—Novartis lures UCSF cardiovascular scientist Coughlin fiercebiotech
August 21, 2017
UCSF cardiovascular scientist Shaun Coughlin left for the Novartis Institutes for BioMedical Research to head up CV and metabolism R&D.